ID: ALA4213250

Max Phase: Preclinical

Molecular Formula: C12H6FN3O2

Molecular Weight: 243.20

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  O=c1oc(-c2ccccc2F)nc2nccnc12

Standard InChI:  InChI=1S/C12H6FN3O2/c13-8-4-2-1-3-7(8)11-16-10-9(12(17)18-11)14-5-6-15-10/h1-6H

Standard InChI Key:  UDSVMNOFWJGGFJ-UHFFFAOYSA-N

Associated Targets(Human)

Coagulation factor VII/tissue factor 740 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 243.20Molecular Weight (Monoisotopic): 243.0444AlogP: 1.78#Rotatable Bonds: 1
Polar Surface Area: 68.88Molecular Species: NEUTRALHBA: 5HBD: 0
#RO5 Violations: 0HBA (Lipinski): 5HBD (Lipinski): 0#RO5 Violations (Lipinski): 0
CX Acidic pKa: CX Basic pKa: CX LogP: 2.04CX LogD: 2.04
Aromatic Rings: 3Heavy Atoms: 18QED Weighted: 0.65Np Likeness Score: -1.29

References

1. Xie Z, Tian Y, Lv X, Xiao X, Zhan M, Cheng K, Li S, Liao C..  (2018)  The selectivity and bioavailability improvement of novel oral anticoagulants: An overview.,  146  [PMID:29407959] [10.1016/j.ejmech.2018.01.067]

Source